Drug For Sexual Desire Extends To New Patient Group
A groundbreaking drug for sexual desire is now accessible to a wider range of patients. – demo.burdah.biz.id BOSTON (WHN) – The U.S. Food and Drug Administration (FDA) has expanded the approved use of Addyi (flibanserin) to include post-menopausal women experiencing low sexual desire. This decision, announced December 15, marks a significant shift in addressing hypoactive … Read more